Caroline K. Kramer

200 Elizabeth Street
Toronto, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 100 publications

Impact of semaglutide withdrawal on cardiometabolic profile and physiology of energy balance: Recovery effects after semaglutide termination - The REST trial study protocol.

Impact of semaglutide withdrawal on cardiometabolic profile and physiology of energy balance: Recovery effects after semaglutide termination - The REST trial study protocol.

Journal: PloS one

Published: June 22, 2026

Time restricted EAting for Type 2 diabetes and MEtabolic health: The TEA TIME trial study protocol.

Time restricted EAting for Type 2 diabetes and MEtabolic health: The TEA TIME trial study protocol.

Journal: PloS one

Published: February 01, 2026

One-Hour Oral Glucose Tolerance Test for the Postpartum Reclassification of Women With Hyperglycemia in Pregnancy.

One-Hour Oral Glucose Tolerance Test for the Postpartum Reclassification of Women With Hyperglycemia in Pregnancy.

Journal: Obstetrical & gynecological survey

Published: December 30, 2025

Exenatide induces an enhanced endogenous glucagon-like peptide-1 secretory response in patients receiving basal insulin.

Exenatide induces an enhanced endogenous glucagon-like peptide-1 secretory response in patients receiving basal insulin.

Journal: The Journal of clinical endocrinology and metabolism

Published: October 31, 2025

Exenatide induces an Enhanced Endogenous Glucagon-like Peptide-1 Secretory Response in Patients receiving Basal Insulin.

Exenatide induces an Enhanced Endogenous Glucagon-like Peptide-1 Secretory Response in Patients receiving Basal Insulin.

Journal: The Journal of clinical endocrinology and metabolism

Published: October 31, 2025

Ocular Adverse Events With Semaglutide: A Systematic Review and Meta-Analysis.

Ocular Adverse Events With Semaglutide: A Systematic Review and Meta-Analysis.

Journal: JAMA ophthalmology

Published: August 14, 2025

GLP-1R Agonists for Weight Loss in Psychiatric Disorders: A Systematic Review and Meta-analysis.

GLP-1R Agonists for Weight Loss in Psychiatric Disorders: A Systematic Review and Meta-analysis.

Journal: Journal of the Endocrine Society

Published: July 21, 2025

Empagliflozin for the preservation of beta-cell function in women with recent gestational diabetes: A randomized placebo-controlled trial.

Empagliflozin for the preservation of beta-cell function in women with recent gestational diabetes: A randomized placebo-controlled trial.

Journal: Diabetes, obesity & metabolism

Published: July 18, 2025

Cardiovascular impact of the national program of publicly-funded access to dapagliflozin in Brazil.

Cardiovascular impact of the national program of publicly-funded access to dapagliflozin in Brazil.

Journal: Public health

Published: June 09, 2025

The coordinated changes in insulin sensitivity and insulin secretion associated with the remission of type 2 diabetes following short-term insulin therapy.

The coordinated changes in insulin sensitivity and insulin secretion associated with the remission of type 2 diabetes following short-term insulin therapy.

Journal: Diabetes, obesity & metabolism

Published: January 23, 2025

The effects of time-restricted eating on energy balance regulation in adults with overweight/obesity and type 2 diabetes.

The effects of time-restricted eating on energy balance regulation in adults with overweight/obesity and type 2 diabetes.

Journal: International journal of obesity (2005)

Published: November 28, 2024

Role of the liver in the sustained normalisation of A1c over 2 years following short-term insulin therapy in early type 2 diabetes.

Role of the liver in the sustained normalisation of A1c over 2 years following short-term insulin therapy in early type 2 diabetes.

Journal: Diabetes, obesity & metabolism

Published: September 23, 2024

Showing 1-12 of 100

Last Updated: 09/26/2026